Spero Therapeutics, Inc. Financial Ratios — SPRO Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-243.37	-72.25	-37.45	-51.83	-60.32	-55.32	-31.37	14.85	-46.81	9.55
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-5.75	- -	-1.9
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	24.61	- -	12.31
Gross Margin (%)	- -	- -	- -	- -	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	- -	-1,317.29	-30,368.99	-2,844.46	-61.13	28.07	-264.57	12.01
Operating Margin (%)	- -	- -	- -	- -	-1,333.11	-30,663.95	-2,865.5	-62.92	27.69	-264.58	12.01
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	119.1	- -	247.16
Pretax Margin (%)	- -	- -	- -	- -	-1,284.8	-30,341.09	-2,923.65	-95.55	26.26	-250.28	14.82
Profit Margin (%)	- -	- -	- -	- -	-1,284.8	-30,341.09	-2,923.65	-95.55	23.58	-250.28	14.38
Net Income to Common Margin (%)	- -	- -	- -	- -	-1,284.8	-30,553.88	-2,923.65	-95.55	23.58	-250.28	14.38
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	10.23	- -	2.95
Dvd Payout Ratio (%)	5.46	7.96	13.03	- -	- -	0.7	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	6	8	7	7	6	4	3
ST Debt	- -	- -	- -	- -	1	1	1	2	2	2	2
LT Debt	- -	- -	- -	- -	5	7	6	5	4	3	1
Total Debt/EBITDA	- -	- -	- -	- -	-0.09	-0.1	-0.08	-0.22	0.2	-0.06	0.4
Net Debt/EBITDA	0.43	0.31	2.11	0.8	0.48	1.09	1.29	3.67	-2.81	0.73	-5.62
Total Debt/EBIT	- -	- -	- -	- -	-0.09	-0.1	-0.08	-0.22	0.21	-0.06	0.4
Net Debt/EBIT	0.43	0.31	2.09	0.8	0.47	1.08	1.28	3.57	-2.85	0.73	-5.62
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-45.01	-11.4	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-45.01	-11.4	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-45.35	-11.73	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	2	3	- -	- -	- -
Common Equity/Total Assets	-252.23	-329.94	-103.58	-107.35	-187.94	-180.96	-214.78	-331.59	-214.39	-415.75	-654.41
Long-Term Debt/Equity (%)	- -	- -	- -	- -	6.19	5.22	6.77	6.53	3.58	5.53	1.59
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-2.38	-2.55	-1.66	-1.22	-0.99	-0.56	-0.21
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	4.35	4.49	3.49	3.97	2.1	2.31	1.36
Total Debt/Equity (%)	- -	- -	- -	- -	7.44	5.94	8.31	8.75	5.19	9.32	4.91
Total Debt/Capital (%)	- -	- -	- -	- -	-2.86	-2.9	-2.04	-1.63	-1.44	-0.94	-0.65
Total Debt/Total Assets (%)	- -	- -	- -	- -	5.23	5.11	4.29	5.33	3.04	3.89	4.2
Net Debt to Equity	2,214.4	-162.16	-102.74	-29.42	-39.87	-64.53	-127.52	-143.69	-71.41	-114.67	-68.22
Net Debt/Capital (%)	95.68	86.84	47.5	19.79	13.3	24	23.82	21.13	16.53	10.41	8.24
EBITDA	-13	-33	-41	-42	-62	-78	-87	-30	27	-72	7
EBITDA-CapEx	-14	-34	-41	-45	-63	-79	-87	-30	27	-72	7
Operating Income (Loss)	-13	-33	-42	-43	-63	-79	-88	-31	27	-72	7

Liquidity (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.89	1.49	10.7	9.37	3.08	8.85	7.84	5.04	2.05	1.08	4.54
Current Ratio	0.93	1.72	11.29	10.08	3.58	9.7	8.46	5.25	3.53	2.19	7.59
Quick Ratio	0.89	1.53	11.06	9.48	3.4	9.28	7.98	5.09	3.42	2.15	7.4
CFO/Avg Current Liab	- -	-4.34	-5.19	-3.87	-2.57	-4.19	-3.9	-0.38	-1.12	-0.54	-0.44
Common Equity/Total Assets	-252.23	-329.94	-103.58	-107.35	-187.94	-180.96	-214.78	-331.59	-214.39	-415.75	-654.41
Long-Term Debt/Equity (%)	- -	- -	- -	- -	6.19	5.22	6.77	6.53	3.58	5.53	1.59
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-2.38	-2.55	-1.66	-1.22	-0.99	-0.56	-0.21
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	4.35	4.49	3.49	3.97	2.1	2.31	1.36
Total Debt/Equity (%)	- -	- -	- -	- -	7.44	5.94	8.31	8.75	5.19	9.32	4.91
Total Debt/Capital (%)	- -	- -	- -	- -	-2.86	-2.9	-2.04	-1.63	-1.44	-0.94	-0.65
Total Debt/Total Assets (%)	- -	- -	- -	- -	5.23	5.11	4.29	5.33	3.04	3.89	4.2
CFO/Total Liabilities	-129.26	-390.76	-458.94	-301.31	-158.65	-401.06	-77.73	-15.82	-43.7	-36.39	-127.54
CFO/CapEx	-41.41	-34.89	-1,448.56	-16.27	-159.3	-546.96	- -	- -	- -	- -	- -
Altman's Z-Score	-9.73	-12.15	0.29	2.93	-0.45	8.91	-0.12	-3.38	-0.75	-6.59	0.97

Working Capital (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	30	98	175	434	495	65	77	56	131
- Cash & Cash Equivalents	6	10	87	34	30	85	113	109	76	53	40
+ Preferred Equity and Hybrid Capital	18	48	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	6	8	7	7	6	4	3
Enterprise Value	12	34	-57	-17	98	315	356	-37	7	7	93
Total Capital	- -	-2	-96	-138	-194	-270	-360	-407	-385	-455	-448
Total Debt/Capital (%)	- -	- -	- -	- -	-2.86	-2.9	-2.04	-1.63	-1.44	-0.94	-0.65
Total Debt / EV	- -	- -	- -	- -	0.06	0.02	0.02	-0.18	0.83	0.61	0.03
EV/Sales	- -	- -	- -	- -	20.71	1,220.94	115.82	- -	0.07	0.26	1.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.25	- -	13.01
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.25	- -	13.01
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	30	98	175	434	495	65	78	56	138
Diluted Enterprise Value	12	34	-57	65	151	357	389	-37	7	7	100
EV per Share	1.84	5.08	- -	- -	5.41	14.07	11.51	- -	0.13	0.13	1.66
TTM Sales	- -	- -	- -	- -	5	- -	3	49	97	27	60
TTM EBITDA	-13	-33	-41	-42	-62	-78	-87	-30	27	-72	7
TTM Operating Income	-13	-33	-42	-43	-63	-79	-88	-31	27	-72	7
TTM Cash Flow to Firm	-10	-29	-39	-40	-50	-86	-62	-5	-33	-23	-13
TTM Free Cash Flow to Firm	-9	-28	-39	-37	-50	-86	-62	-5	-33	-23	-13

Multiples (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-0.78	-2.65	-3.51	-5.06	-7.69	-8.41	-2.36	-2.37	-10.9
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	0.25	- -	13.01
Enterprise Value	12	34	-57	-17	98	315	356	-37	7	7	93
Low Price	- -	- -	9.85	5.52	6	5.25	11.75	0.68	0.99	0.92	0.51
EV/Sales	- -	- -	- -	- -	20.71	1,220.94	115.82	- -	0.07	0.26	1.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	0.25	- -	13.01
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	3.4	- -	15.23
Price/Earnings Average	- -	- -	-0.71	-4.28	-3.28	-3.38	-5.46	-3.22	3.44	-1.1	11.22
Price/Earnings High	- -	- -	-0.89	-7.3	-4.32	-6.71	-7.66	-13.2	4.71	-1.49	21.04
Price/Earnings Low	- -	- -	-0.57	-2.12	-1.79	-1.49	-4.04	-0.55	2.29	-0.72	3.3
Price/Book Value	- -	- -	-0.31	-0.71	-0.88	-1.56	-1.35	-0.16	-0.2	-0.12	-0.29
Price/Book Value Average	- -	- -	-0.33	-1.29	-1	-0.96	-1.33	-0.36	-0.2	-0.16	-0.21
Price/Book Value High	- -	- -	-0.41	-2.2	-1.32	-1.91	-1.87	-1.48	-0.27	-0.22	-0.4
Price/Book Value Low	- -	- -	-0.26	-0.64	-0.55	-0.42	-0.99	-0.06	-0.13	-0.11	-0.06
Price/Tangible Book Value	- -	- -	0.36	0.85	2.34	3.29	5.6	0.86	0.72	1.21	2.21
Price/Tangible Book Value Average	- -	- -	0.37	1.54	2.68	2.02	5.55	1.97	0.73	1.64	1.63
Price/Tangible Book Value High	- -	- -	0.47	2.62	3.53	4.01	7.78	8.07	1.01	2.21	3.06
Price/Tangible Book Value Low	- -	- -	0.3	0.76	1.46	0.89	4.11	0.34	0.49	1.08	0.48
Price/Sales	- -	- -	- -	- -	36.84	1,682.43	161.12	1.34	0.8	2.03	2.19
Price/Sales Average	- -	- -	- -	- -	42.1	1,031.81	159.64	3.07	0.81	2.76	1.61
Price/Sales High	- -	- -	- -	- -	55.45	2,051.19	223.82	12.61	1.11	3.73	3.03
Price/Sales Low	- -	- -	- -	- -	22.98	455.53	118.25	0.53	0.54	1.81	0.47
Price/Cash Flow	- -	- -	-0.78	-2.48	-3.49	-5.05	-7.69	-8.41	-2.35	-2.37	-10.34
Price/Cash Flow Average	- -	- -	-0.81	-4.5	-3.99	-3.1	-7.62	-19.31	-2.38	-3.23	-7.62
Price/Cash Flow High	- -	- -	-1.02	-7.67	-5.26	-6.16	-10.68	-79.24	-3.26	-4.36	-14.29
Price/Cash Flow Low	- -	- -	-0.65	-2.23	-2.18	-1.37	-5.64	-3.31	-1.58	-2.12	-2.24
Price/Free Cash Flow Average	- -	- -	-0.81	-4.8	-4.02	-3.11	-7.62	-19.31	-2.39	-3.23	-8.03
Price/Free Cash Flow High	- -	- -	-1.02	-8.18	-5.29	-6.17	-10.68	-79.24	-3.28	-4.36	-15.06
Price/Free Cash Flow Low	- -	- -	-0.65	-2.38	-2.19	-1.37	-5.64	-3.31	-1.59	-2.12	-2.36
EV/Sales Average	- -	- -	- -	- -	37	731.94	125.36	0.96	0.08	0.99	0.99
EV/Sales High	- -	- -	- -	- -	50.35	1,751.32	189.54	10.5	0.38	1.95	2.4
EV/Sales Low	- -	- -	- -	- -	17.88	155.66	83.97	- -	- -	0.04	- -
EV/EBITDA Average	-0.91	-1.02	1.33	-3.41	-2.81	-2.41	-4.41	-1.58	0.28	-0.37	8.21
EV/EBITDA High	-0.91	-1.02	1.14	-6.38	-3.82	-5.77	-6.66	-17.18	1.35	-0.74	19.98
EV/EBITDA Low	-0.91	-1.02	1.49	-1.29	-1.36	-0.51	-2.95	2.59	-0.69	-0.01	-1.27
EV/EBIT Average	-0.91	-1.01	1.32	-3.38	-2.78	-2.39	-4.37	-1.53	0.29	-0.37	8.21
EV/EBIT High	-0.91	-1.01	1.13	-6.31	-3.78	-5.71	-6.61	-16.69	1.37	-0.74	19.98
EV/EBIT Low	-0.91	-1.01	1.47	-1.28	-1.34	-0.51	-2.93	2.52	-0.69	-0.01	-1.27
Last Price	- -	- -	11.75	6.15	9.62	19.39	16.01	1.73	1.47	1.03	2.33
High Price	- -	- -	15.4	19	14.48	23.64	22.24	16.3	2.04	1.89	3.22
Enterprise Value Average	12	34	-55	145	175	189	385	47	8	27	59
Enterprise Value High	12	34	-47	270	239	452	582	510	37	54	143
Enterprise Value Low	12	34	-61	55	85	40	258	-77	-19	1	-9

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	13	13	14	17	19	29	32	52	53	55	56
Diluted Weighted Avg Shares	7	7	3	16	18	22	31	38	53	54	59
Basic Weighted Avg Shares	7	7	3	16	18	22	31	38	53	54	56
Revenue per Share	- -	- -	- -	- -	0.26	0.01	0.1	1.29	1.84	0.51	1.06
EBITDA per Share	-2.02	-4.99	-15.99	-2.65	-3.44	-3.5	-2.83	-0.79	0.52	-1.34	0.13
Operating Income per Share	-2.02	-5.03	-16.13	-2.68	-3.48	-3.53	-2.85	-0.81	0.51	-1.34	0.13
Basic EPS, GAAP	-1.68	-4.38	-17.35	-2.6	-3.35	-3.52	-2.91	-1.23	0.43	-1.27	0.15
Basic EPS from Cont Ops	-1.99	-4.94	-15.42	-2.6	-3.35	-3.5	-2.91	-1.23	0.43	-1.27	0.15
Diluted EPS, GAAP	-1.68	-4.38	-17.35	-2.6	-3.35	-3.52	-2.91	-1.23	0.43	-1.27	0.15
Diluted EPS from Cont Ops	-1.99	-4.94	-15.42	-2.6	-3.35	-3.5	-2.91	-1.23	0.43	-1.27	0.15
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.45	-4.38	-15.12	-2.48	-2.75	-3.84	-2.08	-0.21	-0.63	-0.43	-0.23
Free Cash Flow per Basic Share	-1.49	-4.51	-15.13	-2.63	-2.77	-3.84	-2.08	-0.21	-0.63	-0.43	-0.23
Cash & Equivalents per Share	0.86	1.56	33.74	7.21	4.52	5.67	4.74	2.9	1.45	0.98	0.72
Book Value per Share	-2.74	-6.88	-37.43	-8.65	-10.98	-12.4	-11.89	-11.01	-7.42	-8.5	-8.05
Tangible Book Value per Share	-2.81	-6.26	32.84	7.24	4.11	5.9	2.86	2.02	2.03	0.85	1.05

Spero Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)